TD Cowen raised the firm’s price target on Amgen (AMGN) to $383 from $381 and keeps a Buy rating on the shares. The firm updated its model and corresponding estimates in conjunction with its Q3 earnings preview.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMGN:
- Uber downgraded, Zoom Video upgraded: Wall Street’s top analyst calls
- Amgen initiated with an Outperform at Bernstein
- Regeneron price target lowered to $1,137 from $1,200 at Truist
- Amgen announces ‘positive’ Phase 3 data for UPLIZNA
- Caterpillar downgraded, Flutter upgraded: Wall Street’s top analyst calls